Cargando…
Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option
Chronic Kidney Disease (CKD) is a frequent complication in patients with multiple myeloma (MM) and is associated with adverse outcomes. The use of autologous stem cell transplantation (ASCT) has improved disease outcomes, however, the safety and efficacy of ASCT in patients with CKD has been the sub...
Autores principales: | Lazana, I., Floro, L., Christmas, T., Shah, S., Bramham, K., Cuthill, K., Bassett, P., Schey, S., Kazmi, M., Potter, V., Pagliuca, A., Streetly, M., Benjamin, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200631/ https://www.ncbi.nlm.nih.gov/pubmed/35413986 http://dx.doi.org/10.1038/s41409-022-01657-y |
Ejemplares similares
-
Risk of relapse of multiple myeloma following kidney transplantation
por: Shah, Sapna, et al.
Publicado: (2019) -
Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial
por: Pawlyn, Charlotte, et al.
Publicado: (2020) -
Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand
por: Lazana, Ioanna
Publicado: (2023) -
Sequential, Autologous Hematopoietic Stem Cell Transplant Followed by Renal Transplant in Multiple Myeloma
por: Bhowmik, D., et al.
Publicado: (2017) -
Autologous transplant for myeloma: when the old meets the new
por: Gay, Francesca, et al.
Publicado: (2017)